A client who is receiving chemotherapy for breast cancer is experiencing myelosuppression as a side effect of the treatment. Which of the following is a manifestation directly related to myelosuppression?

A. Atorvastatin is a statin used to lower cholesterol levels in the blood. Reducing cholesterol levels helps to prevent the progression of atherosclerosis (plaque buildup in the arteries), which is a major cause of chronic stable angina. Statins are commonly prescribed to manage the underlying condition that leads to angina by stabilizing plaques and reducing the risk of heart attacks and strokes.
B. Digoxin is a medication used to treat heart failure and certain types of abnormal heart rhythms (arrhythmias). It works by increasing the force of heart contractions and controlling heart rate. While it can be helpful in specific cases of heart failure or arrhythmias, it is not typically used for the management of chronic stable angina.
C. Furosemide is a diuretic used to treat conditions such as heart failure and edema by removing excess fluid from the body. It helps to reduce fluid buildup but does not address the underlying cause of chronic stable angina or improve coronary artery function. It is not a primary medication for managing angina.
D. Rituximab is a monoclonal antibody used primarily to treat certain types of cancer and autoimmune diseases by targeting specific immune cells. It is not used to treat chronic stable angina or related cardiovascular conditions. It does not play a role in managing cholesterol levels or improving coronary artery health.

Muscle hypertrophy (increase in muscle size) is not a typical manifestation of ALS. In fact, ALS leads to muscle atrophy (wasting) rather than hypertrophy. As motor neurons degenerate, muscles become weaker and smaller because they are no longer receiving adequate nerve signals to maintain strength.
B.A Tinnitus (ringing in the ears) is not a common manifestation of ALS. ALS primarily affects motor neurons and does not usually cause auditory symptoms. Tinnitus is more related to other conditions such as ear infections, exposure to loud noises, or certain neurological conditions, but it is not associated with ALS.
C. Tripping or stumbling is a common manifestation of ALS. As the disease progresses, it causes weakness in the muscles responsible for maintaining balance and coordination. This can lead to difficulties with walking and increased risk of tripping or falling.
D. Confusion is not a typical symptom of ALS. ALS primarily affects motor neurons, leading to muscle weakness and atrophy, but it does not usually affect cognitive function. However, in rare cases, some patients with ALS may develop cognitive or behavioral changes, but these are not the primary symptoms and are less common.
E. Dropping objects is a common manifestation of ALS. Muscle weakness and loss of fine motor control in the hands and arms can make it difficult to hold or manipulate objects, leading to frequent dropping.